VarmX
PrivateLast Round
M&A
Sep 16, 2024
Total Funding Raised
$87.13M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
VarmX is a biotechnology company that develops therapeutic drugs designed to restore blood clotting in bleeding patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VarmX Comparables
Compare VarmX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Perosphere Pharmaceuticals Inc. | 86% | |
| AstraZeneca | 82% | |
| Takeda | 74% | |
VarmX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Sep 16, 2024 | ||||
| Series B Extension | May 25, 2023 | ||||
| Grant | Oct 21, 2021 | ||||
| Series B | Jul 8, 2020 | ||||
| Debt | Jul 2, 2018 | ||||
Series A | Jul 2, 2018 |
Key People
Founding team and executive leadership
VarmX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lundbeck Foundation | Series B |
| European Innovation Council Fund | Grant, Series B Extension |
| EQT Life Sciences | Series B Extension |
| Lundbeckfonden BioCapital | Series B Extension |
| Ysios Capital | Series B Extension, Series B |
| BioGeneration Ventures | Series B Extension, Series B, Seed, Series A |
| Netherlands Enterprise Agency | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors increased 50% MoM.
VarmX Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about VarmX's valuation, stock price, and market status.